Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.

Autor: Palaniehamy, Arumugam1, Jahn, Sarah1, Nickles, Dorothee1, Derstine, Mia1, Abounasr, Aya1, Hauser, Stephen L.1, Baranzini, Sergio E.1, Leppert, David2, von Biidingen, H.-Christian1 Hans-Christian.vonBuedingen@ucsf.edu
Zdroj: Journal of Immunology. 7/15/2014, Vol. 193 Issue 2, p580-586. 7p.
Databáze: Academic Search Ultimate